Water → 5-Bromo-2-(1-methyl-1H-tetrazol-5-yl)pyridine

HRID 1966926Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1966926
[NH:1]1[C:5]([C:6]2[CH:11]=[CH:10][C:9]([Br:12])=[CH:8][N:7]=2)=[N:4][N:3]=[N:2]1.[OH-].[Na+].I[CH3:16].O>CN(C)C=O>[CH3:16][N:4]1[C:5]([C:6]2[CH:11]=[CH:10][C:9]([Br:12])=[CH:8][N:7]=2)=[N:1][N:2]=[N:3]1.[CH3:16][N:3]1[N:2]=[N:1][C:5]([C:6]2[CH:11]=[CH:10][C:9]([Br:12])=[CH:8][N:7]=2)=[N:4]1

Komponenten

7

Versuchsvorschrift

10.5 g of 2-(tetrazol-5-yl)-5-bromopyridine prepared in the Preparation example 6 was dissolved in 100 ml of dimethylformamide. And then 6.5 g of sodiumhydroxide was added to the solution and 9.3 g of iodomethane was slowly added to the solution at the temperature of 0° C. The solution was stirred for 6 hours at room temperature, added with water, extracted with ethyl acetate. And then the organic layer was washed with brine, dehydrated, filtrated, concentrated in vacuo and purified by column chromatography to obtain 4 g of 2-(1-methyltetrazol-5-yl)-5-bromopyridine and 5 g of 2-(2-methyltetrazol-5-yl)-5-bromopyridine.

Aufarbeitung

  1. additionwas slowly added to the solution at the temperature of 0° C
  2. extractionextracted with ethyl acetate
  3. washAnd then the organic layer was washed with brine
  4. filtrationfiltrated
  5. concentrationconcentrated in vacuo
  6. custompurified by column chromatography

Quellen und Nachweise

ORD-Eintrag
ord-76676fab2caa471e91d7dd6ff9e13558
Quelldatensatz
uspto-grants-2013_04
Patentnummer
US08420676B2

Notizen zur Reaktion

Wird geladen…